logo

Galmed Pharmaceuticals Ltd. (GLMD)



Trade GLMD now with
  Date
  Headline
4/9/2019 7:31:48 AM Galmed Announces Successful Completion Of End Of Phase 2 Meeting With FDA And Plan For Start Of Phase 3
3/13/2019 7:02:30 AM Galmed Pharma Q4 Net Loss $3.7 Mln Or $0.18/Shr Vs Loss $3.6 Mln Or $0.27/Shr Last Year
3/12/2019 8:01:56 AM Galmed Reports Positive Results From Pharmacokinetic Split Dose Study Of Aramchol
11/5/2018 7:19:53 AM Galmed Pharma Q3 Loss Per Share $0.05 Vs Loss $0.23 Last Year
8/2/2018 7:17:17 AM Galmed Pharma Q2 Loss Per Share $0.17 Vs Loss $0.22 Last Year
6/19/2018 9:49:47 PM Galmed Pharma Prices Underwritten Public Offering Of 5 Mln Shares At $15.00/shr
6/18/2018 6:32:51 AM Galmed Pharma Intends To Offer Public Offering To Raise Aggregate Proceeds Of About $75 Mln
5/9/2018 7:15:27 AM Galmed Pharma Q1 Net Loss $2.5 Mln Or $0.17/Shr Vs Loss Of $3.2 Mln Or $0.26/Shr Last Year
4/3/2018 7:11:10 AM Galmed Reports Pricing Of $6.0 Mln Registered Direct Offering
3/13/2018 7:10:55 AM Galmed Q4 Net Loss $3.6 Mln Or $0.27 Per Share